Proceedings of the fourth international conference on central hypoventilation

Ha Trang, Jean-François Brunet, Hermann Rohrer, Jorge Gallego, Jeanne Amiel, Tiziana Bachetti, Kenneth H Fischbeck, Thomas Similowski, Christian Straus, Isabella Ceccherini, Debra E Weese-Mayer, Matthias Frerick, Katarzyna Bieganowska, Linda Middleton, Francesco Morandi, Giancarlo Ottonello, European Central Hypoventilation Syndrome Consortium, Marek Migdal, Jochen Peters, Johannes Schoeber, Miriam Katz-Salomon, Agneta Markstrom, Martin Samuels, Angeles Garcia-Teresa, Raquel Porto-Abal, Maria-Helena Estevao, Andrea Pfleger, Moritz Rohrbach, Raffaele Piumelli, Barbara Gnidovec, Irena Senecic, David Kilner, Ha Trang, Jean-François Brunet, Hermann Rohrer, Jorge Gallego, Jeanne Amiel, Tiziana Bachetti, Kenneth H Fischbeck, Thomas Similowski, Christian Straus, Isabella Ceccherini, Debra E Weese-Mayer, Matthias Frerick, Katarzyna Bieganowska, Linda Middleton, Francesco Morandi, Giancarlo Ottonello, European Central Hypoventilation Syndrome Consortium, Marek Migdal, Jochen Peters, Johannes Schoeber, Miriam Katz-Salomon, Agneta Markstrom, Martin Samuels, Angeles Garcia-Teresa, Raquel Porto-Abal, Maria-Helena Estevao, Andrea Pfleger, Moritz Rohrbach, Raffaele Piumelli, Barbara Gnidovec, Irena Senecic, David Kilner

Abstract

Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung's disease (ORPHA99803) and neural crest tumours in 20% and 5% of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways.The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13-15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.

References

    1. Fleming PJ, Cade D, Bryan MH, Bryan AC. Congenital central hypoventilation and sleep state. Pediatrics. 1980;66(3):425–428.
    1. Huang J, Colrain IM, Panitch HB, Tapia IE, Schwartz MS, Samuel J, Pepe M, Bandla P, Bradford R, Mosse YP, Maris JM, Marcus CL. Effect of sleep stage on breathing in children with central hypoventilation. J Appl Physiol. 2008;105(1):44–53. doi: 10.1152/japplphysiol.01269.2007.
    1. Weese-Mayer DE, Silvestri JM, Menzies LJ, Morrow-Kenny AS, Hunt CE, Hauptman SA. Congenital central hypoventilation syndrome: diagnosis, management, and long-term outcome in thirty-two children. J Pediatr. 1992;120(3):381–387. doi: 10.1016/S0022-3476(05)80901-1.
    1. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Silvestri JM, Curran ME, Marazita ML. Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am J Med Genet A. 2003;123A(3):267–278. doi: 10.1002/ajmg.a.20527.
    1. Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, Vekemans M, Munnich A, Gaultier C, Lyonnet S. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet. 2003;33(4):459–461. doi: 10.1038/ng1130.
    1. Onimaru H, Ikeda K, Kawakami K. CO2-sensitive preinspiratory neurons of the parafacial respiratory group express Phox2b in the neonatal rat. J Neurosci. 2008;28(48):12845–12850. doi: 10.1523/JNEUROSCI.3625-08.2008.
    1. Stornetta RL, Moreira TS, Takakura AC, Kang BJ, Chang DA, West GH, Brunet JF, Mulkey DK, Bayliss DA, Guyenet PG. Expression of Phox2b by brainstem neurons involved in chemosensory integration in the adult rat. J Neurosci. 2006;26(40):10305–10314. doi: 10.1523/JNEUROSCI.2917-06.2006.
    1. Ramanantsoa N, Hirsch MR, Thoby-Brisson M, Dubreuil V, Bouvier J, Ruffault PL, Matrot B, Fortin G, Brunet JF, Gallego J, Goridis C. Breathing without CO(2) chemosensitivity in conditional Phox2b mutants. J Neurosci. 2011;31(36):12880–12888. doi: 10.1523/JNEUROSCI.1721-11.2011.
    1. Ramanantsoa N, Matrot B, Vardon G, Lajard AM, Voituron N, Dauger S, Denjean A, Hilaire G, Gallego J. Impaired ventilatory and thermoregulatory responses to hypoxic stress in newborn phox2b heterozygous knock-out mice. Front Physiol. 2011;2:61. doi: 10.3389/fphys.2011.00061.
    1. Idiopathic congenital central hypoventilation syndrome: diagnosis and Thorac Soc Am J Respir Crit Care Med 1999, 160(1):368–373.
    1. Trochet D, Hong SJ, Lim JK, Brunet JF, Munnich A, Kim KS, Lyonnet S, Goridis C, Amiel J. Molecular consequences of PHOX2B missense, frameshift and alanine expansion mutations leading to autonomic dysfunction. Hum Mol Genet. 2005;14(23):3697–3708. doi: 10.1093/hmg/ddi401.
    1. Berry-Kravis EM, Zhou L, Rand CM, Weese-Mayer DE. Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. Am J Respir Crit Care Med. 2006;174(10):1139–1144. doi: 10.1164/rccm.200602-305OC.
    1. Trang H, Dehan M, Beaufils F, Zaccaria I, Amiel J, Gaultier C, French CCHS, Working Group The French Congenital Central Hypoventilation Syndrome Registry: general data, phenotype, and genotype. Chest. 2005;127(1):72–79. doi: 10.1378/chest.127.1.72.
    1. Dauger S, Pattyn A, Lofaso F, Gaultier C, Goridis C, Gallego J, Brunet JF. Phox2b controls the development of peripheral chemoreceptors and afferent visceral pathways. Development. 2003;130(26):6635–6642. doi: 10.1242/dev.00866.
    1. Dubreuil V, Ramanantsoa N, Trochet D, Vaubourg V, Amiel J, Gallego J, Brunet JF, Goridis C. A human mutation in Phox2b causes lack of CO2 chemosensitivity, fatal central apnea, and specific loss of parafacial neurons. Proc Natl Acad Sci U S A. 2008;105(3):1067–1072. doi: 10.1073/pnas.0709115105.
    1. Boden AG, Harris MC, Parkes MJ. Apneic threshold for CO2 in the anesthetized rat: fundamental properties under steady-state conditions. J Appl Physiol (1985) 1998;85(3):898–907.
    1. Dubreuil V, Thoby-Brisson M, Rallu M, Persson K, Pattyn A, Birchmeier C, Brunet JF, Fortin G, Goridis C. Defective respiratory rhythmogenesis and loss of central chemosensitivity in Phox2b mutants targeting retrotrapezoid nucleus neurons. J Neurosci. 2009;29(47):14836–14846. doi: 10.1523/JNEUROSCI.2623-09.2009.
    1. Goridis C, Rohrer H. Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci. 2002;3(7):531–541. doi: 10.1038/nrn871.
    1. Rohrer H, Thoenen H. Relationship between differentiation and terminal mitosis: chick sensory and ciliary neurons differentiate after terminal mitosis of precursor cells, whereas sympathetic neurons continue to divide after differentiation. J Neurosci. 1987;7(11):3739–3748.
    1. Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, Laquaglia MJ, Sennett R, Lynch JE, Perri P, Laureys G, Speleman F, Kim C, Hou C, Hakonarson H, Torkamani A, Schork NJ, Brodeur GM, Tonini GP, Rappaport E, Devoto M, Maris JM. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008;455(7215):930–935. doi: 10.1038/nature07261.
    1. Reiff T, Tsarovina K, Majdazari A, Schmidt M, del Pino I, Rohrer H. Neuroblastoma phox2b variants stimulate proliferation and dedifferentiation of immature sympathetic neurons. J Neurosci. 2010;30(3):905–915. doi: 10.1523/JNEUROSCI.5368-09.2010.
    1. Reiff T, Huber L, Kramer M, Delattre O, Janoueix-Lerosey I, Rohrer H. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition. Development. 2011;138(21):4699–4708. doi: 10.1242/dev.072157.
    1. Weese-Mayer DE, Marazita ML, Rand CM, Berry-Kravis EM. Congenital Central Hypoventilation Syndrome. 2004 Jan 28 [Updated 2014 Jan 30] In: Pagon RA, Adam MP, Ardinger HH, editors. GeneReviews™ [Internet] Seattle (WA): University of Washington, Seattle; 1993-2014.
    1. Trochet D, O'Brien LM, Gozal D, Trang H, Nordenskjold A, Laudier B, Svensson PJ, Uhrig S, Cole T, Niemann S, Munnich A, Gaultier C, Lyonnet S, Amiel J. PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet. 2005;76(3):421–426. doi: 10.1086/428366.
    1. Raabe EH, Laudenslager M, Winter C, Wasserman N, Cole K, LaQuaglia M, Maris DJ, Mosse YP, Maris JM. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene. 2008;27(4):469–476. doi: 10.1038/sj.onc.1210659.
    1. Bernstein ML, Leclerc JM, Bunin G, Brisson L, Robison L, Shuster J, Byrne T, Gregory D, Hill G, Dougherty G. A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol. 1992;10(2):323–329.
    1. Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, Borrego S, Pelet A, Arnold S, Miao X, Griseri P, Brooks AS, Antinolo G, de Pontual L, Clement-Ziza M, Munnich A, Kashuk C, West K, Wong KK, Lyonnet S, Chakravarti A, Tam PK, Ceccherini I, Hofstra RM, Fernandez R, Hirschsprung Disease Consortium Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1–14. doi: 10.1136/jmg.2007.053959.
    1. Khalifa MM, Flavin MA, Wherrett BA. Congenital central hypoventilation syndrome in monozygotic twins. J Pediatr. 1988;113(5):853–855. doi: 10.1016/S0022-3476(88)80016-7.
    1. Silvestri JM, Chen ML, Weese-Mayer DE, McQuitty JM, Carveth HJ, Nielson DW, Borowitz D, Cerny F. Idiopathic congenital central hypoventilation syndrome: the next generation. Am J Med Genet. 2002;112(1):46–50. doi: 10.1002/ajmg.10819.
    1. Matera I, Bachetti T, Puppo F, Di Duca M, Morandi F, Casiraghi GM, Cilio MR, Hennekam R, Hofstra R, Schöber JG, Ravazzolo R, Ottonello G, Ceccherini I. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet. 2004;41(5):373–380. doi: 10.1136/jmg.2003.015412.
    1. Parodi S, Vollono C, Baglietto MP, Balestri M, Di Duca M, Landri PA, Ceccherini I, Ottonello G, Cilio MR. Congenital central hypoventilation syndrome: genotype-phenotype correlation in parents of affected children carrying a PHOX2B expansion mutation. Clin Genet. 2010;78(3):289–293. doi: 10.1111/j.1399-0004.2010.01383.x.
    1. Bachetti T, Bocca P, Borghini S, Matera I, Prigione I, Ravazzolo R, Ceccherini I. Geldanamycin promotes nuclear localisation and clearance of PHOX2B misfolded proteins containing polyalanine expansions. Int J Biochem Cell Biol. 2007;39(2):327–339. doi: 10.1016/j.biocel.2006.08.014.
    1. Trochet D, Mathieu Y, Pontual L, Savarirayan R, Munnich A, Brunet JF, Lyonnet S, Goridis C, Amiel J. Vitro studies of non poly alanine PHOX2B mutations argue against a loss-of-function mechanism for congenital central hypoventilation. Hum Mutat. 2009;30(2):E421–E431. doi: 10.1002/humu.20923.
    1. Jennings LJ, Yu M, Rand CM, Kravis N, Berry-Kravis EM, Patwari PP, Weese-Mayer DE. Variable human phenotype associated with novel deletions of the PHOX2B gene. Pediatr Pulmonol. 2012;47(2):153–161. doi: 10.1002/ppul.21527.
    1. Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, Keens TG, Loghmanee DA, Trang H. An official ATS clinical policy statement: congenital central hypoventilation syndrome: genetic basis, diagnosis, and management. Am J Respir Crit Care Med. 2010;181(6):626–44. doi: 10.1164/rccm.200807-1069ST.
    1. Kijima K, Sasaki A, Niki T, Umetsu K, Osawa M, Matoba R, Hayasaka K. Sudden infant death syndrome is not associated with the mutation of PHOX2B gene, a major causative gene of congenital central hypoventilation syndrome. Tohoku J Exp Med. 2004;203(1):65–68. doi: 10.1620/tjem.203.65.
    1. Rand CM, Patwari PP, Carroll MS, Weese-Mayer DE. Congenital central hypoventilation syndrome and sudden infant death syndrome: disorders of autonomic regulation. Semin Pediatr Neurol. 2013;20(1):44–55. doi: 10.1016/j.spen.2013.01.005.
    1. Ize-Ludlow D, Gray JA, Sperling MA, Berry-Kravis EM, Milunsky JM, Farooqi IS, Rand CM, Weese-Mayer DE. Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics. 2007;120(1):e179–e188. doi: 10.1542/peds.2006-3324.
    1. Parodi S, Bachetti T, Lantieri F, Di Duca M, Santamaria G, Ottonello G, Matera I, Ravazzolo R, Ceccherini I. Parental origin and somatic mosaicism of PHOX2B mutations in Congenital Central Hypoventilation Syndrome. Hum Mutat. 2008;29(1):206. doi: 10.1002/humu.9516.
    1. Bachetti T, Parodi S, Di Duca M, Santamaria G, Ravazzolo R, Ceccherini I. Low amounts of PHOX2B expanded alleles in asymptomatic parents suggest unsuspected recurrence risk in congenital central hypoventilation syndrome. J Mol Med. 2011;89(5):505–513. doi: 10.1007/s00109-010-0718-y.
    1. Shao J, Diamond MI. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet. 2007;16(Spec No. 2):R115–R123. doi: 10.1093/hmg/ddm213.
    1. Amiel J, Trochet D, Clement-Ziza M, Munnich A, Lyonnet S. Polyalanine expansions in human. Hum Mol Genet. 2004;13(Spec No 2):R235–R243. doi: 10.1093/hmg/ddh251.
    1. Riley BE, Orr HT. Polyglutamine neurodegenerative diseases and regulation of transcription: assembling the puzzle. Genes Dev. 2006;20(16):2183–2192. doi: 10.1101/gad.1436506.
    1. La Spada AR, Weydt P, Pineda VV: Huntington’s Disease Pathogenesis: Mechanisms and Pathways. Neurobiology of Huntington's Disease: Applications to Drug Discovery. In Neurobiology of Huntington's Disease: Applications to Drug Discovery Boca Raton (FL). Edited by Lo DC, Hughes RE. CRC Press; 2011. chapter 2.
    1. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352(6330):77–79. doi: 10.1038/352077a0.
    1. Grunseich C, Rinaldi C, Fischbeck K. Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis. 2014;20(1):6–9. doi: 10.1111/odi.12121.
    1. Lund A, Udd B, Juvonen V, Andersen PM, Cederquist K, Davis M, Gellera C, Kölmel C, Ronnevi LO, Sperfeld AD, Sörensen SA, Tranebjaerg L, Van Maldergem L, Watanabe M, Weber M, Yeung L, Savontaus ML. Multiple founder effects in spinal and bulbar muscular atrophy (SBMA, Kennedy disease) around the world. Eur J Hum Genet. 2001;9(6):431–436. doi: 10.1038/sj.ejhg.5200656.
    1. Fischbeck KH, Lieberman A, Bailey CK, Abel A, Merry DE. Androgen receptor mutation in Kennedy's disease. Philos Trans R Soc Lond B Biol Sci. 1999;354(1386):1075–1078. doi: 10.1098/rstb.1999.0461.
    1. Brooks BP, Paulson HL, Merry DE, Salazar-Grueso EF, Brinkmann AO, Wilson EM, Fischbeck KH. Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol Dis. 1997;3(4):313–323. doi: 10.1006/nbdi.1997.0126.
    1. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1993;5(2):184–188. doi: 10.1038/ng1093-184.
    1. Pinsky L, Trifiro M, Kaufman M, Beitel LK, Mhatre A, Kazemi-Esfarjani P, Lady Davis Institute, Sir Mortimer B, Davis-Jewish General Hospital, Montreal, Quebec. Sabbaghian N, Lumbroso R, Alvarado C, Vasiliou M, Pinsky L. Androgen resistance due to mutation of the androgen receptor. Clin Invest Med. 1992;15(5):456–472.
    1. Taylor JP, Hardy J, Fischbeck KH. Toxic proteins in neurodegenerative disease. Science. 2002;296(5575):1991–1995. doi: 10.1126/science.1067122.
    1. Merry DE, Kobayashi Y, Bailey CK, Taye AA, Fischbeck KH. Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum Mol Genet. 1998;7(4):693–701. doi: 10.1093/hmg/7.4.693.
    1. McCampbell A, Taye AA, Whitty L, Penney E, Steffan JS, Fischbeck KH. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc Natl Acad Sci U S A. 2001;98(26):15179–15184. doi: 10.1073/pnas.261400698.
    1. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet. 1998;19(2):148–154. doi: 10.1038/502.
    1. Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE, Mangiarini L, Bates GP. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997;90(3):537–548. doi: 10.1016/S0092-8674(00)80513-9.
    1. Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19(2):333–344. doi: 10.1016/S0896-6273(00)80943-5.
    1. Lieberman AP, Robitaille Y, Trojanowski JQ, Dickson DW, Fischbeck KH. Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease. Lancet. 1998;351(9106):884. doi: 10.1016/S0140-6736(05)70296-8.
    1. Bailey CK, Andriola IF, Kampinga HH, Merry DE. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2002;11(5):515–523. doi: 10.1093/hmg/11.5.515.
    1. Li M, Miwa S, Kobayashi Y, Merry DE, Yamamoto M, Tanaka F, Doyu M, Hashizume Y, Fischbeck KH, Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol. 1998;44(2):249–254. doi: 10.1002/ana.410440216.
    1. Katsuno M, Adachi H, Kume A, Li M, Nakagomi Y, Niwa H, Sang C, Kobayashi Y, Doyu M, Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron. 2002;35(5):843–854. doi: 10.1016/S0896-6273(02)00834-6.
    1. Adachi H, Katsuno M, Minamiyama M, Waza M, Sang C, Nakagomi Y, Kobayashi Y, Tanaka F, Doyu M, Inukai A, Yoshida M, Hashizume Y, Sobue G. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain. 2005;128(Pt 3):659–670. doi: 10.1093/brain/awh381.
    1. Katsuno M, Banno H, Suzuki K, Takeuchi Y, Kawashima M, Yabe I, Sasaki H, Aoki M, Morita M, Nakano I, Kanai K, Ito S, Ishikawa K, Mizusawa H, Yamamoto T, Tsuji S, Hasegawa K, Shimohata T, Nishizawa M, Miyajima H, Kanda F, Watanabe Y, Nakashima K, Tsujino A, Yamashita T, Uchino M, Fujimoto Y, Tanaka F, Sobue G. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9(9):875–884. doi: 10.1016/S1474-4422(10)70182-4.
    1. Fernandez-Rhodes LE, Kokkinis AD, White MJ, Watts CA, Auh S, Jeffries NO, Shrader JA, Lehky TJ, Li L, Ryder JE, Levy EW, Solomon BI, Harris-Love MO, La Pean A, Schindler AB, Chen C, Di Prospero NA, Fischbeck KH. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 2011;10(2):140–147. doi: 10.1016/S1474-4422(10)70321-5.
    1. Healy F, Marcus CL. Congenital central hypoventilation syndrome in children. Paediatr Respir Rev. 2011;12(4):253–263. doi: 10.1016/j.prrv.2010.10.001.
    1. Chatwin M, Nickol AH, Morrell MJ, Polkey MI, Simonds AK. Randomised trial of inpatient versus outpatient initiation of home mechanical ventilation in patients with nocturnal hypoventilation. Respir Med. 2008;102(11):1528–1535. doi: 10.1016/j.rmed.2008.07.019.
    1. Kun SS, Edwards JD, Ward SL, Keens TG. Hospital readmissions for newly discharged pediatric home mechanical ventilation patients. Pediatr Pulmonol. 2012;47(4):409–414. doi: 10.1002/ppul.21536.
    1. Pekcan S, Aslan AT, Kiper N, Kose M, Cobanoglu N, Yalcin E, Doğru D, Ozçelik U. Home mechanical ventilation: outcomes according to remoteness from health center and different family education levels. Turk J Pediatr. 2010;52(3):267–273.
    1. Levine S, Nguyen T, Taylor N, Friscia ME, Budak MT, Rothenberg P, Zhu J, Sachdeva R, Sonnad S, Kaiser LR, Rubinstein NA, Powers SK, Shrager JB. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008;358(13):1327–1335. doi: 10.1056/NEJMoa070447.
    1. Fauroux B, Leroux K, Desmarais G, Isabey D, Clement A, Lofaso F, Louis B. Performance of ventilators for noninvasive positive-pressure ventilation in children. Eur Respir J. 2008;31(6):1300–1307. doi: 10.1183/09031936.00144807.
    1. Fauroux B, Leroux K, Pepin JL, Lofaso F, Louis B. Are home ventilators able to guarantee a minimal tidal volume? Intensive Care Med. 2010;36(6):1008–1014. doi: 10.1007/s00134-010-1785-9.
    1. Oscroft NS, Smith IE. A bench test to confirm the core features of volume-assured non-invasive ventilation. Respirology. 2010;15(2):361–364. doi: 10.1111/j.1440-1843.2009.01691.x.
    1. Gonzalez-Bermejo J, Laplanche V, Husseini FE, Duguet A, Derenne JP, Similowski T. Evaluation of the user-friendliness of 11 home mechanical ventilators. Eur Respir J. 2006;27(6):1236–1243. doi: 10.1183/09031936.06.00078805.
    1. Twork P, Usicenko P, Koch R, Berger B, Bickhardt J, Ragette R, Mellies U, Wigand G, Wolf G, Paditz E. Artificial neural networks for control of home ventilators (Künstliche neuronale Netze zur Steuerung von Heimbeatmungsgeräten) Mon J Pediatr (Monatsschrift Kinderheilkunde) 2003;151(3):274–283. doi: 10.1007/s00112-003-0666-5.
    1. Grasso F, Engelberts D, Helm E, Frndova H, Jarvis S, Talakoub O, McKerlie C, Babyn P, Post M, Kavanagh BP. Negative-pressure ventilation: better oxygenation and less lung injury. Am J Respir Crit Care Med. 2008;177(4):412–418. doi: 10.1164/rccm.200707-1004OC.
    1. Le Pimpec-Barthes F, Gonzalez-Bermejo J, Hubsch JP, Duguet A, Morelot-Panzini C, Riquet M, Similowski T. Intrathoracic phrenic pacing: a 10-year experience in France. J Thorac Cardiovasc Surg. 2011;142(2):378–383. doi: 10.1016/j.jtcvs.2011.04.033.
    1. Onders RP, Elmo M, Khansarinia S, Bowman B, Yee J, Road J, Bass B, Dunkin B, Ingvarsson PE, Oddsdóttir M. Complete worldwide operative experience in laparoscopic diaphragm pacing: results and differences in spinal cord injured patients and amyotrophic lateral sclerosis patients. Surg Endosc. 2009;23(7):1433–1440. doi: 10.1007/s00464-008-0223-3.
    1. Ali A, Flageole H. Diaphragmatic pacing for the treatment of congenital central alveolar hypoventilation syndrome. J Pediatr Surg. 2008;43(5):792–796. doi: 10.1016/j.jpedsurg.2007.12.013.
    1. Romero-Ganuza FJ, Gambarrutta-Malfatti C, DiezdelaLastra-Buigues E, Marin-Ruiz MA, Merlo-Gonzalez VE, Sanchez-Aranzueque Pantoja AM, García-Moreno FJ, Mazaira-Álvarez J. Diaphragmatic pacemaker as an alternative to mechanical ventilation in patients with cervical spinal injury. Med Intensiva. 2011;35(1):13–21. doi: 10.1016/j.medin.2010.10.003.
    1. Hirschfeld S, Exner G, Luukkaala T, Baer GA. Mechanical ventilation or phrenic nerve stimulation for treatment of spinal cord injury-induced respiratory insufficiency. Spinal Cord. 2008;46(11):738–742. doi: 10.1038/sc.2008.43.
    1. Onders RP, Elmo MJ, Ignagni AR. Diaphragm pacing stimulation system for tetraplegia in individuals injured during childhood or adolescence. J Spinal Cord Med. 2007;30(Suppl 1):S25–S29.
    1. Lloyd-Owen SJ, Donaldson GC, Ambrosino N, Escarabill J, Farre R, Fauroux B, Robert D, Schoenhofer B, Simonds AK, Wedzicha JA. Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J. 2005;25(6):1025–1031. doi: 10.1183/09031936.05.00066704.
    1. Dybwik K, Tollali T, Nielsen EW, Brinchmann BS. Why does the provision of home mechanical ventilation vary so widely? Chron Respir Dis. 2010;7(2):67–73. doi: 10.1177/1479972309357497.
    1. Earle RJ, Rennick JE, Carnevale FA, Davis GM. 'It's okay, it helps me to breathe': the experience of home ventilation from a child's perspective. J Child Health Care. 2006;10(4):270–282. doi: 10.1177/1367493506067868.
    1. Carnevale FA. Revisiting Goffman's Stigma: the social experience of families with children requiring mechanical ventilation at home. J Child Health Care. 2007;11(1):7–18. doi: 10.1177/1367493507073057.
    1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC, Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350–e408. doi: 10.1161/CIRCUALTIONAHA.108.189742.
    1. National Scientific Society for the developing child: Young Children Develop in an Environment of Relationships. Center for the developing child at Harvard University. Working paper No1 .
    1. Ray LD. Parenting and Childhood Chronicity: making visible the invisible work. J Pediatr Nurs. 2002;17(6):424–438. doi: 10.1053/jpdn.2002.127172.
    1. Nelson CA: From Neurons to Neighborhoods in The science of early Childhood Development. In Edited by Shonkoff J, Phillips DA. Washington, DC: National Academy Press; 2000.
    1. Morandi F. Personal Communication. Erba, Italy: Conference of the Ospedale Sacra Famiglia; 2010.
    1. Drotar D, Baskiewicz A, Irvin N, Kennell J, Klaus M. The adaptation of parents to the birth of an infant with a congenital malformation: a hypothetical model. Pediatrics. 1975;56(5):710–717.
    1. Vanderlaan M, Holbrook CR, Wang M, Tuell A, Gozal D. Epidemiologic survey of 196 patients with congenital central hypoventilation syndrome. Pediatr Pulmonol. 2004;37(3):217–229. doi: 10.1002/ppul.10438.
    1. Tibballs J, Henning R, Robertson CF, Massie J, Hochmann M, Carter B, Osborne A, Stephens RA, Scoble M, Jones SE, White J, Bryan D. A home respiratory support programme for children by parents and layperson carers. J Paediatr Child Health. 2010;46(1–2):57–62. doi: 10.1111/j.1440-1754.2009.01618.x.
    1. Marcus CL, Jansen MT, Poulsen MK, Keens SE, Nield TA, Lipsker LE, Keens TG. Medical and psychosocial outcome of children with congenital central hypoventilation syndrome. J Pediatr. 1991;119(6):888–895. doi: 10.1016/S0022-3476(05)83038-0.
    1. Kuster PA, Badr LK, Chang BL, Wuerker AK, Benjamin AE. Factors influencing health promoting activities of mothers caring for ventilator-assisted children. J Pediatr Nurs. 2004;19(4):276–287. doi: 10.1016/j.pedn.2004.05.009.
    1. Montirosso R, Morandi F, D'Aloisio C, Berna A, Provenzi L, Borgatti R. International classification of functioning, disability and health in children with congenital central hypoventilation syndrome. Disabil Rehabil. 2009;31(Suppl 1):S144–S152. doi: 10.3109/09638280903317807.
    1. Muzumdar H, Arens R. Central alveolar hypoventilation syndromes. Sleep Med Clin. 2008;3(4):601–615. doi: 10.1016/j.jsmc.2008.08.006.
    1. 194–198 FMQa La progettazione e la gestione di "reti curanti" per bambini con malattie croniche. Quaderni acp. 2005;2(5):194–198.
    1. Dodge JA, Chigladze T, Donadieu J, Grossman Z, Ramos F, Serlicorni A, Siderius L, Stefanidis CJ, Tasic V, Valiulis A, Wierzba J. The importance of rare diseases: from the gene to society. Arch Dis Child. 2011;96(9):791–792. doi: 10.1136/adc.2010.193664.
    1. The Motherhood Constellation . A Unified View of Parent-Infant Psychotherapy. In: Stern DN, editor. In A Unified View of Parent-Infant Psychotherapy. New York: Publisher:Basic Books; 1995.
    1. TE Nathwani AC, Rangarajan S. Adenovirus-associated virus vector mediated gene transfer in hemophilia. N Engl J Med. 2011;365:2357–2365. doi: 10.1056/NEJMoa1108046.
    1. Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Drevinek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS, VX08-770-102 Study Group A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med. 2011;365(18):1663–1672. doi: 10.1056/NEJMoa1105185.
    1. Di Zanni E, Ceccherini I, Bachetti T. Toward a therapeutic strategy for polyalanine expansions disorders: in vivo and in vitro models for drugs analysis. Eur J Paediatr Neurol. 2011;15(5):449–452. doi: 10.1016/j.ejpn.2011.02.005.
    1. Di Zanni E, Bachetti T, Parodi S, Bocca P, Prigione I, Di Lascio S, Fornasari D, Ravazzolo R, Ceccherini I. In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins. Neurobiol Dis. 2012;45(1):508–518. doi: 10.1016/j.nbd.2011.09.007.
    1. Parodi S, Di Zanni E, Di Lascio S, Bocca P, Prigione I, Fornasari D, Pennuto M, Bachetti T, Ceccherini I. The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B. J Mol Med. 2012;90(9):1025–1035. doi: 10.1007/s00109-012-0868-1.
    1. Straus C, Trang H, Becquemin MH, Touraine P, Similowski T. Chemosensitivity recovery in Ondine's curse syndrome under treatment with desogestrel. Respir Physiol Neurobiol. 2010;171(2):171–174. doi: 10.1016/j.resp.2010.03.015.
    1. ClinicalTrials. gov..
    1. Trivedi A, Waters K, Suresh S, Nair R. Congenital central hypoventilation syndrome: four families. Sleep Breath. 2011;15(4):785–789. doi: 10.1007/s11325-010-0439-z.
    1. Hasegawa H, Kawasaki K, Inoue H, Umehara M, Takase M. Japanese society of pediatric pulmonology working G. Epidemiologic survey of patients with congenital central hypoventilation syndrome in Japan. Pediatr Int. 2012;54(1):123–126. doi: 10.1111/j.1442-200X.2011.03484.x.
    1. Al Saadi MM. Congenital central hypoventilation syndrome due to PHOX2B mutation in a Saudi child: a case report. Sleep Breath. 2011;15(4):875–878. doi: 10.1007/s11325-010-0438-0.
    1. Lee CW, Lee JH, Jung EY, Choi SO, Kim CS, Lee SL, Kim DK. Haddad syndrome with PHOX2B gene mutation in a Korean infant. J Korean Med Sci. 2011;26(2):312–315. doi: 10.3346/jkms.2011.26.2.312.
    1. Carroll MS, Patwari PP, Weese-Mayer DE. Carbon dioxide chemoreception and hypoventilation syndromes with autonomic dysregulation. J Appl Physiol. 2010;108(4):979–988. doi: 10.1152/japplphysiol.00004.2010.
    1. Weese-Mayer DE, Berry-Kravis EM, Ceccherini I, Keens TG, Loghmanee DA, Trang H, An Official ATS Clinical Policy Statement Congenital central hypoventilation syndrome, genetic basis, diagnosis, and management. Am J Respir Crit Care Med. 2010;181:626–644. doi: 10.1164/rccm.200807-1069ST.
    1. Zelko FA, Nelson MN, Leurgans SE, Berry-Kravis EM, Weese-Mayer DE. Congenital central hypoventilation syndrome: neurocognitive functioning in school age children. Pediatr Pulmonol. 2010;45(1):92–98. doi: 10.1002/ppul.21170.
    1. Battisti A, Tassaux D, Janssens JP, Michotte JB, Jaber S, Jolliet P. Performance characteristics of 10 home mechanical ventilators in pressure-support mode: a comparative bench study. Chest. 2005;127(5):1784–1792. doi: 10.1378/chest.127.5.1784.
    1. Thille AW, Lyazidi A, Richard JC, Galia F, Brochard L. A bench study of intensive-care-unit ventilators: new versus old and turbine-based versus compressed gas-based ventilators. Intensive Care Med. 2009;35(8):1368–1376. doi: 10.1007/s00134-009-1467-7.
    1. Vignaux L, Tassaux D, Jolliet P. Performance of noninvasive ventilation modes on ICU ventilators during pressure support: a bench model study. Intensive Care Med. 2007;33(8):1444–1451. doi: 10.1007/s00134-007-0713-0.
    1. Ramirez A, Delord V, Khirani S, Leroux K, Cassier S, Kadlub N, Aubertin G, Picard A, Fauroux B. Interfaces for long-term noninvasive positive pressure ventilation in children. Intensive Care Med. 2012;38(4):655–662. doi: 10.1007/s00134-012-2516-1.
    1. Falck F, Frankel R. Clinical relevance of step-by-step mandibular advancement in the treatment of mandibular retrusion using the Frankel appliance. Am J Orthod Dentofacial Orthop. 1989;96(4):333–341. doi: 10.1016/0889-5406(89)90353-3.
    1. Villa MP, Pagani J, Ambrosio R, Ronchetti R, Bernkopf E. Mid-face hypoplasia after long-term nasal ventilation. Am J Respir Crit Care Med. 2002;166(8):1142–1143. doi: 10.1164/ajrccm.166.8.257c.
    1. Patel AG PK, Morris DE, Zhao L, Talavera F, Newsome RE, Slenkovich N, de la Torre JI: Orthognathic Surg. .
    1. Niazi AU, Mocon A, Varadi RG, Chan VW, Okrainec A. Ondine’s curse: anesthesia for laparoscopic implantation of a diaphragm pacing stimulation system. Canadian J Anaesthesia = J Canadien d'anesthesie. 2011;58(11):1034–1038. doi: 10.1007/s12630-011-9580-9.
    1. Kezirian EJ, Boudewyns A, Eisele DW, Schwartz AR, Smith PL, Van de Heyning PH, De Backer WA. Electrical stimulation of the hypoglossal nerve in the treatment of obstructive sleep apnea. Sleep Med Rev. 2010;14(5):299–305. doi: 10.1016/j.smrv.2009.10.009.
    1. Mehta A, Qian J, Petocz P, Darendeliler MA, Cistulli PA. A randomized, controlled study of a mandibular advancement splint for obstructive sleep apnea. Am J Respir Crit Care Med. 2001;163(6):1457–1461. doi: 10.1164/ajrccm.163.6.2004213.
    1. Marcus CL, Radcliffe J, Konstantinopoulou S, Beck SE, Cornaglia MA, Traylor J, DiFeo N, Karamessinis LR, Gallagher PR, Meltzer LJ. Effects of positive airway pressure therapy on neurobehavioral outcomes in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185(9):998–1003. doi: 10.1164/rccm.201112-2167OC.
    1. Hebra A, Smith VA, Lesher AP. Robotic Swenson pull-through for Hirschsprung's disease in infants. Am Surg. 2011;77(7):937–941.
    1. Pini Prato A, Musso M, Ceccherini I, Mattioli G, Giunta C, Ghiggeri GM, Jasonni V. Hirschsprung disease and congenital anomalies of the kidney and urinary tract (CAKUT): a novel syndromic association. Medicine (Baltimore) 2009;88(2):83–90. doi: 10.1097/MD.0b013e31819cf5da.
    1. Felemban O, Leroux K, Aubertin G, Miandy F, Damagnez F, Amorim B, Ramirez A, Fauroux B. Value of gas exchange recording at home in children receiving non-invasive ventilation. Pediatr Pulmonol. 2011;46(8):802–808. doi: 10.1002/ppul.21427.
    1. Seifert GJ, Hedin DS, Dahlstrom RJ, Havey GD: Telemedicine Enabled Remote Critical Care Ventilator.: Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Conference; 2010:1150–1153. 2010.
    1. AISICC .
    1. d'Ondine AFdS: Association Française du Syndrome d’Ondine.
    1. Meltzer LJ, Boroughs DS, Downes JJ. The relationship between home nursing coverage, sleep, and daytime functioning in parents of ventilator-assisted children. J Pediatr Nurs. 2010;25(4):250–257. doi: 10.1016/j.pedn.2009.01.007.
    1. Dybwik K, Tollali T, Nielsen EW, Brinchmann BS. "Fighting the system": families caring for ventilator-dependent children and adults with complex health care needs at home. BMC Health Serv Res. 2011;11:156. doi: 10.1186/1472-6963-11-156.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren